FDA Import Refusal AEK-7952222-1/40003/1 — CIPLA LTD
The FDA refused shipment AEK-7952222-1/40003/1 from CIPLA LTD (India) on Dec 5, 2025. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Dec 5, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75